Cancer care issues MCOs priority level U.S. 2016

Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

This survey depicts the level of priority MCOs placed on cancer care issues in the United States in 2016. The survey shows that the issue of specialty drug management earns the highest mean priority level of 8.2 from a range of 1 to 10.

Level of priority on cancer care issues placed by managed care organizations (MCOs) in the United States as of 2016*

Cancer care issues	Mean priority level
Specialty drug management	8.2
Cancer screening and early detection	7.9
Palliative care	7.5
Advance care planning/hospice care	7.5
Case management and care navigation	7.4
Standardization of drug therapy via guidelines/pathways	6.8
Shared decision making	6.7
Centers of excellence team-based care	6.7
Standardization of radiologic care services via guidelines/pathways	6.5
Precision care via molecular/biomarker testing and genetic counseling	6.2
Survivorship care	5.4

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

2017

More information

Region

United States

Survey time period

July to October 2016

Number of respondents

103 managed care organizations (MCOs)

Method of interview

Online survey

Supplementary notes

* 10-point scale, 1 = very low priority, 10 = very high priority
The survey in total includes data from following groups: managed care organizations (MCOs), specialty pharmacies (SPs), oncologists, oncology practice managers (OPMs), employers that sponsor health benefits.

Citation formats